Takeda: all 1,753 studies

Page 12 of 18. Open to participants first (93), then studies with results posted, then the rest; newest registration first within each.

• Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaCompletedNCT00312845Phase 3Results posted
• Long-term Safety of Alogliptin in Patients With Type 2 Diabetes MellitusCompletedNCT00306384Phase 3Results posted
• Open-Label Phase 1/2 Study of VELCADE for Injection in Patients With Light-chain (AL)-AmyloidosisCompletedNCT00298766Phase 1/2Results posted
• Dose-Response Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia ACompletedNCT00289536Phase 4Results posted
• C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) AttacksCompletedNCT00289211Phase 3Results posted
• Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes MellitusCompletedNCT00286494Phase 3Results posted
• Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.CompletedNCT00286468Phase 3Results posted
• Efficacy and Safety of Alogliptin in Subjects With Type 2 DiabetesCompletedNCT00286455Phase 3Results posted
• Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes MellitusCompletedNCT00286442Phase 3Results posted
• Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.CompletedNCT00286429Phase 3Results posted
• Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE)CompletedNCT00262080Phase 3Results posted
• Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat HeartburnCompletedNCT00255190Phase 3Results posted
• Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive EsophagitisCompletedNCT00255164Phase 3Results posted
• Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive EsophagitisCompletedNCT00255151Phase 3Results posted
• Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat HeartburnCompletedNCT00251758Phase 3Results posted
• Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat HeartburnCompletedNCT00251745Phase 3Results posted
• Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive EsophagitisCompletedNCT00251719Phase 3Results posted
• Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive EsophagitisCompletedNCT00251693Phase 3Results posted
• Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia ACompletedNCT00243386Phase 4Results posted
• Pharmacokinetic Study of ARALAST (Human Alpha1- PI)CompletedNCT00242385Phase 1Results posted
• Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes MellitusCompletedNCT00225277Phase 3Results posted
• A Study of Anagrelide and Hydroxyurea in High-Risk Essential Thrombocythemia PatientsCompletedNCT00202644Phase 4Results posted
• Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010CompletedNCT00175019Phase 3Results posted
• Validation Study of Physical Measurement of TophiCompletedNCT00175006Results posted
• Dose-Response, Safety and Efficacy of Febuxostat in Subjects With GoutCompletedNCT00174967Phase 2Results posted
• Magnetic Resonance Imaging in Subjects With Gouty TophiCompletedNCT00174954Results posted
• Long-Term Safety of Febuxostat in Subjects With Gout.CompletedNCT00174941Phase 2Results posted
• Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.CompletedNCT00174915Phase 3Results posted
• Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)CompletedNCT00172185Phase 3Results posted
• Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A PatientsCompletedNCT00157157Phase 3Results posted
• Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17CompletedNCT00152009Phase 3Results posted
• Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedNCT00151996Phase 2Results posted
• Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative ColitisCompletedNCT00151892Phase 3Results posted
• Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17CompletedNCT00150618Phase 3Results posted
• Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17CompletedNCT00150592Phase 2Results posted
• Febuxostat Versus Allopurinol Control Trial in Subjects With GoutCompletedNCT00102440Phase 3Results posted
• Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary AngioedemaCompletedNCT00097695Phase 3Results posted
• Replagal Enzyme Replacement Therapy for Children With Fabry DiseaseCompletedNCT00084084Phase 2Results posted
• Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel SyndromeCompletedNCT00081458Phase 3Results posted
• Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II)CompletedNCT00069641Phase 2/3Results posted
• A Study for Patients With Neurogenic Orthostatic HypotensionCompletedNCT00046475Phase 4Results posted
• A Study of Home vs Hospital Treatment in People With Fabry, Gaucher or Hunter Conditions in MexicoTerminatedNCT07494058
• A Trial of TAK-861 for the Treatment of Narcolepsy With CataplexyActive, not recruitingNCT07363720Phase 3
• Epidemiology of Narcolepsy Type 1 and Type 2 in SpainActive, not recruitingNCT07299097
• A Study of Lanadelumab in Children With Hereditary Angioedema (HAE) in Multiple CountriesCompletedNCT07251933
• A Study on Infections in Adults With Ulcerative Colitis/Crohn's DiseaseWithdrawnNCT07250815
• A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy AdultsActive, not recruitingNCT07047521Phase 3
• A Study of Teduglutide in Chinese Adults With Short Bowel SyndromeActive, not recruitingNCT06973304Phase 3
• A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque PsoriasisCompletedNCT06973291Phase 3
• A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy AdultsCompletedNCT06793943Phase 1
• A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in JapanCompletedNCT06741683Phase 2/3
• A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in BelgiumActive, not recruitingNCT06677892
• A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesActive, not recruitingNCT06671496Phase 3
• A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) InfectionCompletedNCT06615921
• A Study to Explore Hereditary Angioedema (HAE) Symptoms and Treatment Patterns in Korean PeopleCompletedNCT06587464
• A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)Active, not recruitingNCT06579755Phase 3
• A Study of Cytomegalovirus (CMV) Infection After Kidney Transplant in Adults in the United KingdomCompletedNCT06568055
• A Study of TAK-279 in Participants With Moderate-to-Severe Plaque PsoriasisActive, not recruitingNCT06550076Phase 3
• A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) InfectionsCompletedNCT06439342Phase 3
• A Study on the Outcomes of Recombinant Von Willebrand Factor on Demand Treatment and Prevention and Treatment of Bleeding During and After Surgery in Adults With Inherited Von Willebrand Disease in the United Kingdom (UK)CompletedNCT06433778
• A Study on Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS) in Children, Teenagers and Adults in PortugalWithdrawnNCT06395792
• A Study to Monitor the Adverse Events of QDENGA Vaccine in Participants in MalaysiaActive, not recruitingNCT06388785
• A Study of TAK-007 in Adults With Refractory Lupus Nephritis (LN) or Refractory Systemic Sclerosis (SSc)WithdrawnNCT06377228Phase 1
• A Study of Lanadelumab (Takhzyro) and Icatibant (Firazyr®) in Persons With HAE in ChinaCompletedNCT06346899
• A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic PsoriasisCompletedNCT06323356Phase 3
• A Study of the Interaction of Other Drugs With TAK-279 in Healthy AdultsCompletedNCT06290050Phase 1
• A Study of TAK-279 in Healthy Adults on the Effect on ECG MeasurementsCompletedNCT06258265Phase 1
• A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT06254950Phase 2
• A First-In-Human Study of TAK-004 in Healthy AdultsCompletedNCT06236009Phase 1
• A Study of Maribavir in Adults and Children With Post-transplant Cytomegalovirus (CMV) Infection in ArgentinaCompletedNCT06213974
• Expanded Access to TAK-113 for Adults With Metastatic Colorectal Cancer (mCRC)No longer availableNCT06195514
• At-Home Subcutaneous Immunoglobulin Replacement Therapy Using Alexa SkillCompletedNCT06150534
• A Study of TAK-279 in Healthy Chinese AdultsCompletedNCT06111547Phase 1
• A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment PeriodCompletedNCT06108544Phase 3
• A Study in Adults With Advanced Classical Hodgkin's Lymphoma (cHL) in Brazil Treated With Brentuximab Vedotin Together With Chemotherapy Compared to Chemotherapy AloneWithdrawnNCT06104878
• A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)Active, not recruitingNCT06095128Phase 4
• A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of TreatmentCompletedNCT06088043Phase 3
• A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency DiseasesActive, not recruitingNCT06076642Phase 3
• A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's DiseaseActive, not recruitingNCT06045754Phase 4
• Extension Study of Idursulfase-IT Along With Elaprase in Children and Adults With Hunter Syndrome and Cognitive ImpairmentActive, not recruitingNCT06031259Phase 2/3
• A Study of the Interaction of TAK-279 With Substances That Have an Impact on Metabolism in Healthy AdultsCompletedNCT05995249Phase 1
• A Study of TAK-279 in Adults With or Without Kidney ProblemsCompletedNCT05992155Phase 1
• A Study to Gather Information About Overall Occurrence and New Cases of Dravet and Lennox-Gastaut Syndromes in Children, Teenagers and Adults in SpainCompletedNCT05982717
• A Study of TAK-279 in Adults With or Without Liver DamageCompletedNCT05976321Phase 1
• An Extension Study to Learn About the Long-Term Safety of Fazirsiran and if Fazirsiran Can Help People With Alpha-1 Antitrypsin Liver DiseaseActive, not recruitingNCT05899673Phase 3
• A Study About Fazirsiran in People With and Without Liver ProblemsCompletedNCT05891158Phase 1
• A Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab VedotinCompletedNCT05886478
• Drug Use Study With Intuniv® in European CountriesCompletedNCT05870605
• A Real World Study of Mobocertinib in Adults With Lung Cancer in China (MEANING)WithdrawnNCT05863819
• A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal SurgeryTerminatedNCT05814016Phase 2
• A Study to Describe Mothers' and Babies' Outcomes After Exposure to HyQvia During PregnancyCompletedNCT05803200
• Expanded Access Program of TAK-755 for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)Approved for marketingNCT05770219
• A Study to Learn About Metachromatic Leukodystrophy (MLD) in Children in SpainWithdrawnNCT05755568
• A Study to Evaluate Available Treatment Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and Nilotinib in Adults With Chronic Myeloid LeukemiaCompletedNCT05743465
• A Study to Learn About the Tests Looking for a Gene Mutation in Adults With Lung Cancer in China (ELEGANT)WithdrawnNCT05737849
• A Study of Brigatinib as Preferred First Therapy for Adults With Non-Small Cell Lung Cancer (NSCLC) ENTIRETYActive, not recruitingNCT05735327
• A Study to Learn About Brigatinib Treatment Information Available in Chinese Participants With Non-Small-cell Lung Cancer (NSCLC)Active, not recruitingNCT05721950
• A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)CompletedNCT05714969Phase 2
• A Study Measuring Substances Potentially Indicating Bone Problems in Adults With Type 1 Gaucher ConditionCompletedNCT05702814
• A Survey to Describe the Experience and Unmet Needs of Persons Living With Von Willebrand Disease (VWD) and Their CaregiversCompletedNCT05695560

← Takeda overview and focus areas